Photodynamic therapy of subfoveal choroidal neovascularization (CNV) in pathologic myopia using verteporfin: Two-year results - VIP report #4.

被引:0
作者
Lim, JI [1 ]
机构
[1] Univ So Calif, Doheny Eye Inst, VIP Study Grp, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1637
引用
收藏
页码:S304 / S304
页数:1
相关论文
共 50 条
[31]   Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization - One-year results from a prospective case series [J].
Chan, WM ;
Lam, DSC ;
Wong, TH ;
Lai, TYY ;
Kwok, AKH ;
Tam, BSM ;
Li, KKW .
OPHTHALMOLOGY, 2003, 110 (12) :2395-2402
[32]   Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review (vol 18, pg 955, 2008) [J].
Costagliola, C. ;
Campa, C. ;
Incorvala, C. ;
Parmeggiani, F. ;
Menzione, M. ;
Della Corte, M. ;
Rinaldi, M. ;
Romano, M. ;
Semeraro, F. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2009, 19 (02) :329-329
[33]   Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy [J].
Noémi Maár ;
Erdem Ergun ;
Alexandra Luksch ;
Michael Stur .
Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, 244
[34]   Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. [J].
Ergun, E ;
Heinzl, H ;
Stur, W .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 138 (03) :434-438
[35]   Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy [J].
Maar, Noemi ;
Ergun, Erdem ;
Luksch, Alexandra ;
Stur, Michael .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2006, 244 (10) :1262-1266
[36]   Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up [J].
Lam, DSC ;
Chan, WM ;
Liu, DTL ;
Fan, DSP ;
Lai, WW ;
Chong, KKL .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (10) :1315-1319
[37]   Verteporfin photodynamic therapy for the treatment of persistent subfoveal choroidal neovascularization after external beam radiotherapy: One-year results [J].
Gupta, R ;
Browning, AC ;
Wu, K ;
Sokal, M ;
Amoaku, WM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (03) :561-562
[38]   Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration using verteporfin (Visudyne): Two year results of 2 randomized clinical trials - TAP report #5 [J].
Bressler, SB .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) :S532-S532
[39]   Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia [J].
Srivastava, SK ;
Sternberg, P .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2002, 22 (05) :669-671
[40]   A Long-Term Study of Photodynamic Therapy with Verteporfin for Choroidal Neovascularization at the Edge of Chorioretinal Atrophy in Pathologic Myopia [J].
Pece, Alfredo ;
Milani, Paolo ;
Isola, Vincenzo ;
Pierro, Luisa .
OPHTHALMOLOGICA, 2011, 225 (03) :161-168